We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-20.97%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$184M
AUM Growth
-$292M
Cap. Flow
-$238M
Cap. Flow %
-129.38%
Top 10 Hldgs %
72.16%
Holding
80
New
10
Increased
15
Reduced
25
Closed
17

Top Buys

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$79.3M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$4.15M
3
SCHB icon
Schwab US Broad Market ETF
SCHB
+$3.16M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.41M
5
RMD icon
ResMed
RMD
+$1.6M

Top Sells

Rank Stock Value
1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$160M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$47M
3
VGK icon
Vanguard FTSE Europe ETF
VGK
+$25.8M
4
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$18.7M
5
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$18.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.2%
2 Healthcare 26.49%
3 Real Estate 1.23%
4 Materials 0.28%
5 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
51
Illumina
ILMN
$32.6B
$296K 0.16%
1,731
-317
-15% -$64.1K
HNGR
52
DELISTED
Hanger Inc.
HNGR
$284K 0.15%
+20,836
New +$401K
DLN icon
53
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$253K 0.14%
7,520
– –
IWB icon
54
iShares Russell 1000 ETF
IWB
$49.1B
$253K 0.14%
2,368
-12,251
-84% -$1.39M
AAL icon
55
American Airlines Group
AAL
$9.03B
$242K 0.13%
+6,238
New +$256K
CELG
56
DELISTED
Celgene Corp
CELG
$227K 0.12%
+2,100
New +$261K
VGT icon
57
Vanguard Information Technology ETF
VGT
$147B
$224K 0.12%
+17,912
New +$235K
RGLS
58
DELISTED
Regulus Therapeutics
RGLS
$211K 0.11%
269
– –
ASRT
59
DELISTED
Assertio
ASRT
$189K 0.1%
167
– –
HALO icon
60
Halozyme
HALO
$12B
$164K 0.09%
+12,230
New +$246K
BIOC
61
DELISTED
Biocept, Inc.
BIOC
$87K 0.05%
1
– –
SEEL
62
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
ACAD icon
63
Acadia Pharmaceuticals
ACAD
$5.02B
– –
-5,000
Closed -$209K
CRDF icon
64
Cardiff Oncology
CRDF
$73.1M
– –
-157
Closed -$115K
DBC icon
65
Invesco DB Commodity Index Tracking Fund
DBC
$1.82B
– –
-52,021
Closed -$936K
EEM icon
66
iShares MSCI Emerging Markets ETF
EEM
$31.2B
– –
-65,937
Closed -$2.61M
EFA icon
67
iShares MSCI EAFE ETF
EFA
$79.6B
– –
-3,468
Closed -$220K
FTGC icon
68
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.23B
– –
-754,305
Closed -$18.7M
HEPA
69
DELISTED
Hepion Pharmaceuticals
HEPA
– –
0
– -$52K
IVV icon
70
iShares Core S&P 500 ETF
IVV
$898B
– –
-1,570
Closed -$325K
SDY icon
71
State Street SPDR S&P Dividend ETF
SDY
$22B
– –
-616,724
Closed -$47M
SJNK icon
72
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
– –
-53,246
Closed -$1.54M
ITCI
73
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-23,232
Closed -$742K
ARNA
74
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-23,200
Closed -$1.08M
SGYP
75
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-150,100
Closed -$1.25M
1 2
3
4

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Callan Capital held 80 positions worth $184M, down 61% from $477M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Callan Capital withdrew a net $238M in Q3 2015, closing 17 positions and reducing 25 holdings. Its most notable exit was RECEPTOS INC COM STK (DE), an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 97% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Callan Capital opened a new position in ImmunityBio worth $41.6M.

  • Callan Capital's largest Q3 2015 buy was ImmunityBio: 3,632,461 shares worth $41.6M.
  • Callan Capital added most to Vanguard Energy ETF in Q3 2015, an estimated $1.03M increase.
  • Callan Capital's biggest Q3 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $25.8M.
  • Callan Capital fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $160M.
  • Callan Capital's ten largest holdings make up 72% of its $184M portfolio in Q3 2015.
  • Callan Capital opened 10 new positions and closed 17 in Q3 2015.
  • Callan Capital's portfolio value fell 61% quarter-over-quarter to $184M.

Based on Callan Capital's 13F filing for Q3 2015, filed 10 Nov 2015.